Hapbee

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...

Adding Galaxy Digital (GLXY) $5.19 to Watch List.

Here's your back-door into Bitcoin, which as you are probably aware is on a tear once again (see chart below). News of...

Dalrada (DFCO) Removes Shell Company Status.

LIVE QUOTE SAN DIEGO, Nov. 6, 2020 SAN DIEGO , Nov. 6,...
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Teledoc, Biotech Stock Review

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

A number of recent price target changes have been made on Teladoc Health, including: Piper Sandler raises target price...
Hapbee, Biotech Stock Review

Hapbee Technologies (HAPB): Updates and News Archive.

Recent Headlines UPDATED CONTINUOUSLY. June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
Hapbee, Biotech Stock Review

Hapbee (HAPB) Soars 136% the First Day of Trading!

LIVE QUOTE Subscribe here for upcoming report.
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
CB Scientific, Biotech Stock Review

Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.

MyCardia's My-Cam Offers At-Home Heart Rate Monitoring. LIVE QUOTE

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!